Predisposition of infants with chronic lung disease to respiratory syncytial virus-induced respiratory failure: A vascular hypothesis

Pediatric Infectious Disease Journal

Volumn 23, Issue 1 SUPPL., 2004, Pages

  Carpenter, Todd C ^a   Stenmark, Kurt R ^a   Boeckh, Michael J ^b   Gern, James E ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b NONE

Author keywords

Chronic lung disease bronchopulmonary dysplasia; Lower respiratory tract infection; Preterm infants; Pulmonary hypertension; Respiratory failure; Respiratory syncytial virus

Indexed keywords

ATELECTASIS; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CONFERENCE PAPER; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; HIGH RISK POPULATION; HUMAN; INFANT; LUNG ALVEOLUS EPITHELIUM; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG EDEMA; MORTALITY; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS;

EID: 0842327797     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000108191.13799.09     Document Type: Conference Paper

References (49)

1. Simoes EA. Respiratory syncytial virus infection. Lancet 1999;354:847-52.
2. Weisman LE. Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: infants with predisposing conditions. Pediatr Infect Dis J 2003;22(Suppl):S33-9.
3. Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1995;126:212-19.
4. Boyce TG, Mellen BG, Mitchel EF, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr 2000;137:865-70.
5. The Impact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high risk infants. Pediatrics 1998;102:531-7.
6. Carbonell-Estrany X, Quero J. Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons. Pediatr Infect Dis J 2001;20:874-9.
7. Groothuis JR, Gutierrez KM, Lauer BA. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics 1988;82:199-203.
8. Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol 2003;8:73-81.
9. Bonikos DS, Bensch KG, Northway WH, Edwards DK. Bronchopulmonary dysplasia: the pulmononary pathologic sequel of necrotizing bronchiolitis and pulmonary fibrosis. Hum Pathol 1976;7:643-66.
10. Husain A, Siddiqui N, Stocker J. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998;29:710-7.
11. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;164:1971-80.
12. Coalson J. Pathology of chronic lung disease of early infancy. In: Bland R, Coalson J, eds. Chronic lung disease of early infancy. New York: Dekker, 2000:85-124.
13. Jobe AH, Ikegami M. Lung development and function in preterm infants in the surfactant treatment era. Annu Rev Physiol 2000;62:825-46.
14. Langston C, Kida D, Reed M, Thurlbeck W. Human lung growth in late gestation and in the neonate. Am Rev Respir Dis 1984;129:607-13.
15. Burri PH. Structural aspects of prenatal and postnatal development and growth of the lung. In: McDonald JA, ed. Lung growth and development. New York: Dekker, 1997:1-35.
16. Cardoso WV. Molecular regulation of lung development. Annu Rev Physiol 2001;63:471-94.
17. Warburton D, Schwarz M, Tefft D, Flores-Delgardo G, Anderson KD, Cardoso WV. The molecular basis of lung morphogenesis. Mech Dev 2000;92:55-81.
18. Massaro GD, Massaro D. Formation of pulmonary alveoli and gas-exchange surface are: quantitation and regulation. Annu Rev Physiol 1996;58:73-92.
19. Stenmark KR, Gebb SA. Lung vascular development: breathing new life into an old problem. Am J Respir Cell Mol Biol 2003;28:133-7.
20. Cheu HW, Lally KP, Clark R, Harrell S, Null D. Open lung biopsy in the critically ill newborn. Pediatrics 1990;86:561-3.
21. Thibeault D, Mabry SM, Ekekezie II, Truog WE. Lung elastic tissue maturation and perturbations during the evolution of chronic lung disease. Pediatrics 2000;106:1452-9.
22. Tomashefski J, Oppermann H, Vawter G. BPD: a morphometric study with emphasis on the pulmonary vasculature. Pediatr Pathol 1984;2:469-87.
23. Hislop A, Haworth S. Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease. Pediatr Pulmonol 1990;9:152-61.
24. Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999;160:1333-46.
25. Maniscalco WM, Watkins RH, Pryhuber GS, Bhatt A, Shea C, Huyck H. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol 2002;282:L811-23.
26. Albertine KH, Jones GP, Starcher BC, et al. Chronic lung injury in preterm lambs. Am J Respir Crit Care Med 1999;159:945-58.
27. Miyazaki Y, Araki K, Vesin C, et al. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. J Clin Invest 1995;96:250-9.
28. Groneck P, Speer CP. Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child 1995;73:F1-3.
29. Hardie WD, Bruno MD, Huelsman KM, et al. Postnatal lung function and morphology in transgenic mice expressing transforming growth factor-alpha. Am J Pathol 1997;151:1075-83.
30. Speer CP. Inflammation and bronchopulmonary dysplasia. Semin Neonatol 2003;8:29-38.
31. Matthay MA, Folkesson HG, Clerici C. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 2002;82:569-600.
32. Matthay MA, Clerici C, Saumon G. Invited review: active fluid clearance from the distal air spaces of the lung. J Appl Physiol 2002;93:1533-41.
33. Michael JR, Markewitz BA. Endothelins and the lung. Am J Respir Crit Care Med 1996;154:555-81.
34. Kuebler WM, Parthasarathi K, Wang PM, Bhattacharya J. A novel signaling mechanism between gas and blood compartments of the lung. J Clin Invest 2000;105:905-13.
35. Abman SH. Bronchopulmonary dysplasia: a vascular hypothesis. Am J Respir Crit Care Med 2001;164:1755-6.
36. MacDonald NE, Hall CB, Suffin SC, Alexson C, Harris PJ, Manning JA. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med 1982;307:397-400.
37. Ali MH, Schlidt SA, Chandel NS, Hynes KL, Schumacker PT, Gewertz BL. Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction. Am J Physiol 1999;277:L1057-65.
38. Sheeran, P, Jafri H, Carubelli C, et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 1999;18:115-22.
39. Ponnuraj EM, Hayward AR, Raj A, Wilson H, Simoes EA. Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine. J Gen Virol 2001;82:2663-74.
40. Lee CG, Yoon HJ, Zhu Z, et al. Respiratory syncytial virus stimulation of vascular endothelial cell growth factor/vascular permeability factor. Am J Respir Cell Mol Biol 2000;23:662-9.
41. Kuebler WM, Ying X, Singh B, Issekutz AC, Bhattacharya J. Pressure is proinflammatory in lung venular capillaries. J Clin Invest 1999;104:495-502.
42. Costello ML, Mathieu-Costello O, West JB. Stress failure of alveolar epithelial cells studied by scanning electron microscopy. Am Rev Respir Dis 1992;145:1446-55.
43. West JB. Invited review: pulmonary capillary stress failure. J Appl Physiol 2000;89:2483-9.
44. Fu Z, Heldt GP, West JB. Increased fragility of pulmonary capillaries in newborn rabbit. Am J Physiol Lung Cell Mol Physiol 2003;284:L703-9.
45. Carpenter TC, Schomberg S, Nichols C, Stenmark KR, Weil JV. Hypoxia reversibly inhibits epithelial sodium transport but does not inhibit lung ENaC or Na-K-ATPase expression. Am J Physiol Lung Cell Mol Physiol 2003;284:L77-83.
46. Tomlinson LA, Carpenter TC, Baker EH, Bridges JB, Weil JV. Hypoxia reduces airway epithelial sodium transport in rats. Am J Physiol Lung Cell Mol Physiol 1999;277:L881-6.
47. Vivona ML, Matthay M, Chabaud MB, Friedlander G, Clerici C. Hypoxia reduces alveolar epithelial sodium and fluid transport in rats: reversal by beta-adrenergic agonist treatment. Am J Respir Cell Mol Biol 2001;25:554-61.
48. Kunzelmann K, Beesley AH, King NJ, Karupiah G, Young JA, Cook DI. Influenza virus inhibits amiloride-sensitive Na+ channels in respiratory epithelia. Proc Natl Acad Sci USA 2000;97:10282-7.
49. Towne JE, Harrod KS, Krane CM, Menon AG. Decreased expression of aquaporin (AQP)i and AQP5 in mouse lung after acute viral infection. Am J Respir Cell Mol Biol 2000;22:34-44.